Mumbai: Ipca Labs has announced that the Company has incorporated a wholly owned subsidiary named ‘Ipca Pharmaceuticals GmbH’ in the Federal Republic of Germany.
The newly formed subsidiary has an initial paid-up capital of €25,000.
The primary objective of Ipca Pharmaceuticals GmbH is to hold product registrations, participate in institutional and other business activities, and undertake the distribution of generic formulations across the country.
Read also: Ipca Labs appoints Dr Nagaji Ambabhai Vekariya as President – CRD
Established in 1949, lpca is a pharmaceutical company. lpca is vertically integrated and produces finished dosage forms and active pharmaceutical ingredients. For more than 70 years, lpca has been a crucial healthcare partner in over 120 countries across the globe. lpca markets its branded formulations in India and rest of the world markets and generic formulations in United States, Europe, United Kingdom, Canada, Australia & New Zealand. APls manufactured by lpca are marketed across the globe.
